Diabetic macular oedema

Ophthalmologist Dr James Muecke and South Australian colleagues have reported 15 cases of people reversing their diabetic macular oedema (DMO)...

Data collected by Specsavers has revealed KeepSight – Australia’s diabetes eye check reminder program – is significantly enhancing patient adherence...

The Australian Therapeutic Goods Administration (TGA) has approved Eylea 8mg, a higher dose of aflibercept for adults with neovascular aged-related...

Specsavers optometrists nationwide have reached one million appointments registered with the KeepSight national diabetes eye check reminder program. This number...

  Bayer’s high dose aflibercept 8 mg – now approved in the European Union and US – has been labelled...

The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...

There are up to 1.9 million people living with diabetes in Australia. Of those, research suggests 800,000 don’t access routine...

A new Diabetes Australia (DA) report has revealed the spiralling impact of diabetes and warned that unless urgent action is...

Dr James Muecke, Australian of the Year 2020 and passionate advocate for type 2 diabetes prevention, has shared a positive...

A pioneering study out of Western Australia has shown that a longer acting intravitreal dexamethasone implant (DEX-implant) may lead to...